Sana Biotechnology, Inc.
SANA
$3.58
-$0.02-0.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.34M | 11.48M | 17.28M | 14.05M | 16.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.06M | 48.77M | 51.86M | 61.53M | 52.74M |
| Operating Income | -44.06M | -48.77M | -51.86M | -61.53M | -52.74M |
| Income Before Tax | -93.80M | -49.39M | -49.07M | -59.92M | -50.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -93.80M | -49.39M | -49.07M | -59.92M | -50.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.80M | -49.39M | -49.07M | -59.92M | -50.29M |
| EBIT | -44.06M | -48.77M | -51.86M | -61.53M | -52.74M |
| EBITDA | -41.21M | -45.12M | -48.06M | -57.47M | -48.85M |
| EPS Basic | -0.39 | -0.21 | -0.21 | -0.25 | -0.21 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.12 | -0.16 | -0.14 |
| EPS Diluted | -0.39 | -0.21 | -0.21 | -0.25 | -0.21 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.12 | -0.16 | -0.14 |
| Average Basic Shares Outstanding | 238.41M | 237.58M | 236.30M | 235.41M | 234.44M |
| Average Diluted Shares Outstanding | 238.41M | 237.58M | 236.30M | 235.41M | 234.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |